I agree that this site is using cookies. You can find further informations here.
X
Conklyn, Maryrose
16  results:
Search for persons X
?
1

Optimization and validation of a flow cytometric method for..:

Baker, Deanna L. ; Finco‐Kent, Deborah L. ; Reagan, William J...
Veterinary Clinical Pathology.  37 (2008)  1 - p. 42-48 , 2008
Link: https://doi.org/10.1111/..
 
?
2

The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory..:

Kudlacz, Elizabeth ; Conklyn, Maryrose ; Andresen, Catharine..
European Journal of Pharmacology.  582 (2008)  1-3 - p. 154-161 , 2008
Link: https://doi.org/10.1016/..
 
?
3

The JAK3 inhibitor CP-690550 selectively reduces NK and CD8..:

Conklyn, Maryrose ; Andresen, Catharine ; Changelian, Paul.
Journal of Leukocyte Biology.  76 (2004)  6 - p. 1248-1255 , 2004
Link: https://doi.org/10.1189/..
 
?
4

Potent small molecule CCR1 antagonists:

Kath, John C ; Brissette, William H ; Brown, Matthew F...
Bioorganic & Medicinal Chemistry Letters.  14 (2004)  9 - p. 2169-2173 , 2004
Link: https://doi.org/10.1016/..
 
?
5

Novel CCR1 antagonists with improved metabolic stability:

Brown, Matthew F ; Avery, Mike ; Brissette, William H...
Bioorganic & Medicinal Chemistry Letters.  14 (2004)  9 - p. 2175-2179 , 2004
Link: https://doi.org/10.1016/..
 
?
6

The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppr..:

Kudlacz, Elizabeth ; Perry, Bret ; Sawyer, Perry...
American Journal of Transplantation.  4 (2004)  1 - p. 51-57 , 2004
Link: https://doi.org/10.1046/..
 
?
7

CP-481,715, a Potent and Selective CCR1 Antagonist with Pot..:

Gladue, Ronald P. ; Tylaska, Laurie A. ; Brissette, William H....
Journal of Biological Chemistry.  278 (2003)  42 - p. 40473-40480 , 2003
Link: https://doi.org/10.1074/..
 
?
8

Prevention of Organ Allograft Rejection by a Specific Janus..:

Changelian, Paul S. ; Flanagan, Mark E. ; Ball, Douglas J....
Science.  302 (2003)  5646 - p. 875-878 , 2003
Link: https://www.jstor.org/st..
 
?
9

Prevention of Organ Allograft Rejection by a Specific Janus..:

Changelian, Paul S. ; Flanagan, Mark E. ; Ball, Douglas J....
Science.  302 (2003)  5646 - p. 875-878 , 2003
Link: https://doi.org/10.1126/..
 
?
10

Pharmacokinetics and pharmacodynamics of the leukotriene B4..:

Liston, Theodore E. ; Conklyn, Maryrose J. ; Houser, Janet...
British Journal of Clinical Pharmacology.  45 (1998)  2 - p. 115-121 , 1998
Link: https://doi.org/10.1046/..
 
?
11

trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivative..:

Reiter, Lawrence A. ; Koch, Kevin ; Piscopio, Anthony D....
Bioorganic & Medicinal Chemistry Letters.  8 (1998)  14 - p. 1781-1786 , 1998
Link: https://doi.org/10.1016/..
 
?
12

3-Substituted-4-hydroxy-7-chromanylacetic acid derivatives ..:

Reiter, Lawrence A. ; Melvin Jr., Lawrence S. ; Crean, Geraldine L....
Bioorganic & Medicinal Chemistry Letters.  7 (1997)  17 - p. 2307-2312 , 1997
Link: https://doi.org/10.1016/..
 
?
13

Chemokine-Dependent Upregulation of CD11b on Specific Leuko..:

Conklyn, Maryrose J. ; Neote, Kuldep ; Showell, Henry J.
Cytokine.  8 (1996)  10 - p. 762-766 , 1996
Link: https://doi.org/10.1006/..
 
?
14

Tyrosine phosphorylation is an early signaling event common..:

Connelly, Patricia A. ; Farrell, Cathy A. ; Merenda, Joseph M...
Biochemical and Biophysical Research Communications.  177 (1991)  1 - p. 192-201 , 1991
Link: https://doi.org/10.1016/..
 
?
15

Properties of lymphocyte 5′nucleotidase in normal subjects ..:

Conklyn, Maryrose J. ; Silber, Robert
Leukemia Research.  6 (1982)  2 - p. 203-210 , 1982
Link: https://doi.org/10.1016/..
 
1-15